The world of neonatology and in particular surfactant research will be a different place in 2009 following the death of Professor Bengt Robertson in Stockholm on Sunday 7th December 2008. He suffered his final illness with great dignity and fortitude, and news of his death was met with great sadness by his many friends and colleagues worldwide. As an example, Colin Morley from Melbourne commented 'Bengt has been one of my research heroes since I was a fellow in the 1970s when I read his seminal papers about surfactant in rabbit pups. The extraordinary thing about Bengt is that he continued to do very relevant and high quality research on surfactant all his life. He was the primary leader in surfactant research all his working life continuing to produce innovative and significant findings right up to the end'. Bengt A. Robertson was born on 14th September 1935 in Stockholm just 6 years after Kurt van Neergaard, another Swede, first recognised the importance of pulmonary surfactant for normal lung function [1] [2] , two trials of nebulised synthetic surfactant, composed of dipalmitoylphosphatidylcholine (DPPC), showed negative results in the treatment of RDS [3, 4] . In the early 1970s it was Bengt Robertson and Goran Enhorning who discovered the reasons for the failure of nebulised synthetic surfactant when they reported that natural surfactant instilled into the tracheas of immature rabbits was an effective treatment for RDS [5, 6] . For surfactant to be an effective treatment, a natural preparation containing surfactant proteins needs to be instilled directly into the lungs of preterm infants. This was the major breakthrough in surfactant research that led to many later clinical trials with natural surfactant preparations. At the same time, Bengt worked with a young Paediatric Surgeon, Gertie Grossmann, who was later to become his partner and mother to their four younger daughters. Bengt also had four children from his first marriage: one daughter and three sons who were born between 1956 and 1962 when Bengt was studying at the Karolinska Institutet.
Following these early studies with natural surfactant in immature rabbits, Bengt Robertson, together with Tore Curstedt from the Department of Clinical Chemistry at the Karolinska Institutet, developed a porcine surfactant that they later called Curosurf, a name derived from the first two letters of their surnames [7] . After animal testing, Curosurf was studied in a randomised controlled trial to treat preterm babies suffering from severe RDS [8] . This trial was conducted by the Collaborative European Multicenter Study Group, a collection of neonatologists and basic scientists from many countries in Europe, brought together by Bengt Robertson. Curosurf was shown to reduce pulmonary air leaks and neonatal mortality in preterm infants with severe RDS [8] and later studies helped to define dosing regimens [9, 10] , the optimal timing of treatment [11] [12] [13] and the role of surfactant combined with CPAP [14, 15] . Bengt Robertson was the driving force behind these impressive clinical trials and their importance was in helping to determine the optimal regimens for surfactant treatment in the preterm infant [16] . Undoubtedly, the work of Bengt Robertson led to the saving of many thousands of lives of premature babies worldwide and in 1996 he was awarded the King Faisal International Prize for Medicine jointly with Tetsuro Fujiwara from Japan for their studies with surfactant leading to improved survival of the premature infant.
Bengt Robertson received many other awards and honours during his lifetime recognising his prodigious research in the field of surfactant replacement therapy. by his many postgraduate students as an excellent teacher and mentor. From 1974 he supervised a number of doctoral students, all of whom became distinguished academic professors in many parts of the world. We, as authors of this obituary, have good reason to be especially thankful for having met Bengt Robertson at very important times in our lives and we certainly owe him a lot. With his open, warm and charming personality as well as his unpretentious character and his brilliant mind, he stimulated and inspired us in many ways and helped us develop important research collaborations and projects.
But more than this, he was a true friend and colleague; we will miss him dearly. The world of surfactant research and neonatology in general will be a poorer place in 2009 with the passing of Bengt Robertson. However, the legacy that he has left will remain to stimulate other younger clinicians and researchers who will carry forward his ideas to benefit premature babies worldwide. We send our condolences to his wider family circle.
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